help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hosokawa, K.
Right arrow Articles by Amsterdam, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hosokawa, K.
Right arrow Articles by Amsterdam, A.
Endocrinology Vol. 139, No. 11 4688-4700
Copyright © 1998 by The Endocrine Society


ARTICLES

Modulation of Mdm2 Expression and p53-Induced Apoptosis in Immortalized Human Ovarian Granulosa Cells1

Kumiko Hosokawa, Dorit Aharoni, Ada Dantes, Eitan Shaulian, Carolina Schere-Levy, Ruth Atzmon, Fumikazu Kotsuji, Moshe Oren, Israel Vlodavsky and Abraham Amsterdam2

Department of Molecular Cell Biology, The Weizmann Institute of Science (K.H., D.A., A.D., E.S., C.S.-L., M.O., A.A.), Rehovot 76100, Israel; Department of Oncology, Hadassah-Hebrew University Hospital (R.A., I.V.), Jerusalem 91120, Israel; and Department of Obstetrics and Gynecology, Fukui Medical University (K.H., F.K.), Fukui 910–1193, Japan

Address all correspondence and requests for reprints to: A. Amsterdam, Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 76100, Israel. E-mail: lhamster{at}weizmann.weizmann.ac.il

The activity of the tumor suppressor gene p53 is implicated in arrest of the cell cycle and the induction of apoptosis. The mdm2 oncogene is transcriptionally activated by p53, and the protein products of this gene can down-modulate biochemical activities and biological effects of p53 in a cell context-dependent manner. We have established highly steroidogenic human granulosa cell lines expressing the Ha-ras oncogene and a temperature sensitive (ts) mutant of p53 (p53val135) to test the involvement of p53-downstream genes in the modulation of apoptosis in these cells. We find that ras-transformed granulosa cells expressing p53val135 undergo apoptosis following a shift from 37 C to 32 C, a temperature at which p53val135 exerts its wild-type activity. Elevating the cellular content of cAMP at 32 C markedly enhances apoptosis. Basic fibroblast growth factor (bFGF) effectively blocks the p53/cAMP-induced apoptosis, but suppresses steroidogenesis. A naturally produced basement membrane-like extracellular matrix (ECM) containing immobilized bFGF exerts a similar antiapoptotic effect, but unlike soluble bFGF, it enhances steroidogenesis in these cells. While cAMP markedly suppresses the p53-induced Mdm2 expression, bFGF and ECM elevate Mdm2 expression 3–5-fold. These effects on Mdm2 expression are most pronounced 2–4 h after the shift to 32 C, before nuclear fragmentation is detected. Cells grown at 32 C in contact with ECM have a more developed actin cytoskeleton both in the absence and presence of cAMP stimulation, compared with cells grown on plastic dishes. We conclude that bFGF and components of the ECM can cross-talk with p53/cAMP-generated signals for apoptosis. These signals may, at least in part, be coordinated by the modulation of Mdm2 expression, which precedes the biochemical events characteristic of apoptosis. The multicomponent ECM also induced differentiation in these ras-transformed cells, while soluble bFGF inhibited differentiation, suggesting that ECM components other than bFGF stimulate differentiation. Organization of the actin cytoskeleton is likely to play an important role in the cross-talk between p53/cAMP- and bFGF/ECM-generated signals. Because the tumor supressor gene p53 is implicated with apoptosis of primary granulosa cells and the ECM is involved in the prevention of this process, the newly established cell lines can serve as a useful model for apoptosis in highly luteinized granulosa cells.




This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
M. R. Hussein
Apoptosis in the ovary: molecular mechanisms
Hum. Reprod. Update, March 1, 2005; 11(2): 162 - 178.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Cherian-Shaw, R. Das, C. A. VandeVoort, and C. L. Chaffin
Regulation of Steroidogenesis by p53 in Macaque Granulosa Cells and H295R Human Adrenocortical Cells
Endocrinology, December 1, 2004; 145(12): 5734 - 5744.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
R. Sasson, E. Rimon, A. Dantes, T. Cohen, V. Shinder, A. Land-Bracha, and A. Amsterdam
Gonadotrophin-induced gene regulation in human granulosa cells obtained from IVF patients. Modulation of steroidogenic genes, cytoskeletal genes and genes coding for apoptotic signalling and protein kinases
Mol. Hum. Reprod., May 1, 2004; 10(5): 299 - 311.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
R. SASSON, A. DANTES, K. TAJIMA, and A. AMSTERDAM
Novel genes modulated by FSH in normal and immortalized FSH-responsive cells: new insights into the mechanism of FSH action
FASEB J, July 1, 2003; 17(10): 1256 - 1266.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Sasson and A. Amsterdam
Stimulation of Apoptosis in Human Granulosa Cells from in Vitro Fertilization Patients and Its Prevention by Dexamethasone: Involvement of Cell Contact and Bcl-2 Expression
J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3441 - 3451.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
K. Tajima, M. Orisaka, K. Hosokawa, A. Amsterdam, and F. Kotsuji
Effects of Ovarian Theca Cells on Apoptosis and Proliferation of Granulosa Cells: Changes During Bovine Follicular Maturation
Biol Reprod, June 1, 2002; 66(6): 1635 - 1639.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
K. Tajima, K. Hosokawa, Y. Yoshida, A. Dantes, R. Sasson, F. Kotsuji, and A. Amsterdam
Establishment of FSH-responsive cell lines by transfection of pre-ovulatory human granulosa cells with mutated p53 (p53val135) and Ha-ras genes
Mol. Hum. Reprod., January 1, 2002; 8(1): 48 - 57.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. J. Peluso, A. Pappalardo, and G. Fernandez
Basic Fibroblast Growth Factor Maintains Calcium Homeostasis and Granulosa Cell Viability by Stimulating Calcium Efflux via a PKC{delta}-Dependent Pathway
Endocrinology, October 1, 2001; 142(10): 4203 - 4211.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
A. Amsterdam, K. Kannan, D. Givol, Y. Yoshida, K. Tajima, and A. Dantes
Apoptosis of Granulosa Cells and Female Infertility in Achondroplastic Mice Expressing Mutant Fibroblast Growth Factor Receptor 3G374R
Mol. Endocrinol., September 1, 2001; 15(9): 1610 - 1623.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. Sasson, K. Tajima, and A. Amsterdam
Glucocorticoids Protect against Apoptosis Induced by Serum Deprivation, Cyclic Adenosine 3',5'-Monophosphate and p53 Activation in Immortalized Human Granulosa Cells: Involvement of Bcl-2
Endocrinology, February 1, 2001; 142(2): 802 - 811.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Makrigiannakis, K. Amin, G. Coukos, J. L. Tilly, and C. Coutifaris
Regulated Expression and Potential Roles of p53 and Wilms' Tumor Suppressor Gene (WT1) during Follicular Development in the Human Ovary
J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 449 - 459.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
K. Hosokawa, A. Dantes, C. Schere-Levy, A. Barash, Y. Yoshida, F. Kotsuji, I. Vlodavsky, and A. Amsterdam
Induction of Ad4BP/SF-1, Steroidogenic Acute Regulatory Protein, and Cytochrome P450scc Enzyme System Expression in Newly Established Human Granulosa Cell Lines
Endocrinology, November 1, 1998; 139(11): 4679 - 4687.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1998 by The Endocrine Society